Mutational profiles of metastatic colorectal cancer treated ...Wiley Online Library
onlinelibrary.wiley.com
von A Stahler · · Zitiert von: 4 — Arndt Stahler, Medical Department, Division of Hematology, Oncology and Tumor Immunology (CCM), Charité Universitaetsmedizin Berlin, ... von A Stahler · · Zitiert von: 4 — Arndt Stahler, Medical Department, Division of Hematology, Oncology and Tumor Immunology (CCM), Charité Universitaetsmedizin Berlin, ...
Amphiregulin Expression Is a Predictive Biomarker for EGFR ...aacrjournals.org
aacrjournals.org
von A Stahler · · Zitiert von: 23 — Arndt Stahler. ORCID logo ;. Arndt Stahler *. 1Department of Internal Medicine III and Comprehensive Cancer Centre Munich, University ... von A Stahler · · Zitiert von: 23 — Arndt Stahler. ORCID logo ;. Arndt Stahler *. 1Department of Internal Medicine III and Comprehensive Cancer Centre Munich, University ...
Prognostic and predictive impact of metastatic organ ...Wiley Online Library
onlinelibrary.wiley.com
von G Sommerhäuser · · Zitiert von: 1 — Arndt Stahler: Investigation, Writing—Review & Editing. Volker Heinemann: Conceptualization, Investigation, Writing—Review & Editing ... von G Sommerhäuser · · Zitiert von: 1 — Arndt Stahler: Investigation, Writing—Review & Editing. Volker Heinemann: Conceptualization, Investigation, Writing—Review & Editing ...
Mutational profiles of metastatic colorectal cancer treated with ...Freie Universität Berlin
refubium.fu-berlin.de
von A Stahler · · Zitiert von: 4 — Arndt Stahler, Medical Department, Division of Hematology, Oncology and Tumor. Immunology (CCM), Charité. Universitaetsmedizin Berlin, Charitéplatz. 1, von A Stahler · · Zitiert von: 4 — Arndt Stahler, Medical Department, Division of Hematology, Oncology and Tumor. Immunology (CCM), Charité. Universitaetsmedizin Berlin, Charitéplatz. 1,
Depth of response of induction therapy and consecutive ...ScienceDirect.com
www.sciencedirect.com
von G Sommerhäuser · · Zitiert von: 2 — Arndt Stahler: Investigation, Writing – review and editing. Volker Heinemann: Conceptualisation, Investigation, Writing – review and editing. Swantje Held: Data ... von G Sommerhäuser · · Zitiert von: 2 — Arndt Stahler: Investigation, Writing – review and editing. Volker Heinemann: Conceptualisation, Investigation, Writing – review and editing. Swantje Held: Data ...
FIRE-9 – PORT / AIO-KRK-0418: a prospective, randomized ...BMC Cancer
bmccancer.biomedcentral.com
von N Raschzok · · Zitiert von: 1 — Sebastian Stintzing, Annika Kurreck, Annabel H. S. Alig, Arndt Stahler, Lars Bullinger & Dominik P. Modest. German Cancer Consortium, German ... von N Raschzok · · Zitiert von: 1 — Sebastian Stintzing, Annika Kurreck, Annabel H. S. Alig, Arndt Stahler, Lars Bullinger & Dominik P. Modest. German Cancer Consortium, German ...
Gender-dependent survival benefit from first-line irinotecan ...ScienceDirect.com
www.sciencedirect.com
von K Heinrich · · Zitiert von: 17 — Arndt Stahler b c , Marlies Michl a b , Swantje Held n , Andreas Jung b o ... Arndt Stahler: Honoraria: Roche. Travel, Accommodations, Expenses: AMGEN ... von K Heinrich · · Zitiert von: 17 — Arndt Stahler b c , Marlies Michl a b , Swantje Held n , Andreas Jung b o ... Arndt Stahler: Honoraria: Roche. Travel, Accommodations, Expenses: AMGEN ...
Health-related quality of life in patients with RAS wild-type ...ScienceDirect.com
www.sciencedirect.com
von A Ballhausen · · Zitiert von: 3 — ... Knees a , Annika Kurreck a , Arndt Stahler a , Swantje Held i , Stefan Kasper j , Kathrin Heinrich k , Volker Heinemann k l , Sebastian Stintzing ... von A Ballhausen · · Zitiert von: 3 — ... Knees a , Annika Kurreck a , Arndt Stahler a , Swantje Held i , Stefan Kasper j , Kathrin Heinrich k , Volker Heinemann k l , Sebastian Stintzing ...
a meta-analysis of 14 randomized phase III trialsSpringer
link.springer.com
von A Stahler · · Zitiert von: 10 — Arndt Stahler, Volker Heinemann, Ingrid Ricard, Clemens Giessen-Jung ... Arndt Stahler received honoria for talks by Roche and ... von A Stahler · · Zitiert von: 10 — Arndt Stahler, Volker Heinemann, Ingrid Ricard, Clemens Giessen-Jung ... Arndt Stahler received honoria for talks by Roche and ...
Efficacy of FOLFIRI plus cetuximab vs ...Nature
www.nature.com
von LE Fischer · · Zitiert von: 5 — Modest & Arndt Stahler. Gesundheitszentrum St. Marien, Amberg, Germany. Ludwig Fischer von Weikersthal. Oncological Practice, Ravensburg ... von LE Fischer · · Zitiert von: 5 — Modest & Arndt Stahler. Gesundheitszentrum St. Marien, Amberg, Germany. Ludwig Fischer von Weikersthal. Oncological Practice, Ravensburg ...
The Oncology Biomarker Discovery framework reveals ...Nature
www.nature.com
von AJ Ohnmacht · · Zitiert von: 4 — Arndt Stahler, Sebastian Stintzing & Dominik P. Modest. German Cancer Consortium (DKTK), partner sites Berlin and Munich, German Cancer ... von AJ Ohnmacht · · Zitiert von: 4 — Arndt Stahler, Sebastian Stintzing & Dominik P. Modest. German Cancer Consortium (DKTK), partner sites Berlin and Munich, German Cancer ...
Alle Infos zum Namen "Arndt Stahler"
Consensus Molecular Subtypes as Biomarkers ...National Institutes of Health (NIH) (.gov)
pubmed.ncbi.nlm.nih.gov
von A Stahler · · Zitiert von: 5 — Jun 1;41(16): doi: JCO Epub Apr 5. Authors. Arndt Stahler , Beeke Hoppe , Il-Kang Na , Luisa Keilholz , Lothar ... von A Stahler · · Zitiert von: 5 — Jun 1;41(16): doi: JCO Epub Apr 5. Authors. Arndt Stahler , Beeke Hoppe , Il-Kang Na , Luisa Keilholz , Lothar ...
Efficacy of FOLFIRI plus cetuximab vs ...Europe PMC
europepmc.org
von LE Fischer · · Zitiert von: 5 — ... Arndt Stahler,2 Lena Weiss,1 Kathrin Heinrich,1 Swantje Held,19 Andreas Jung,20 Thomas Kirchner,20 and Volker Heinemann1,21. Laura E. Fischer. 1Department of ... von LE Fischer · · Zitiert von: 5 — ... Arndt Stahler,2 Lena Weiss,1 Kathrin Heinrich,1 Swantje Held,19 Andreas Jung,20 Thomas Kirchner,20 and Volker Heinemann1,21. Laura E. Fischer. 1Department of ...
Negative hyperselection for mutations associated with anti ...ASCO Publications
ascopubs.org
von AJ Kind · · Zitiert von: 2 — ... Arndt Stahler Show FewerAuthors Info & Affiliations. Publication: Journal of Clinical Oncology. Volume 40, Number 16_suppl · https://doi.org JCO von AJ Kind · · Zitiert von: 2 — ... Arndt Stahler Show FewerAuthors Info & Affiliations. Publication: Journal of Clinical Oncology. Volume 40, Number 16_suppl · https://doi.org JCO
a meta-analysis of 14 randomized phase III trials. - Abstract ...Europe PMC
europepmc.org
von A Stahler · · Zitiert von: 10 — Current treatment options in RAS mutant metastatic colorectal cancer patients: a meta-analysis of 14 randomized phase III trials. Arndt Stahler. von A Stahler · · Zitiert von: 10 — Current treatment options in RAS mutant metastatic colorectal cancer patients: a meta-analysis of 14 randomized phase III trials. Arndt Stahler.
a prospective, randomized, open, multicenter Phase III trial ...Europe PMC
europepmc.org
von N Raschzok · · Zitiert von: 1 — ... Arndt Stahler,3 Lars Bullinger,3 Moritz Schmelzle,1 Wenzel Schöning,1 Georg Lurje,1 Felix Krenzien,1,2 Oliver Haase,1 Beate Rau,1 Bernhard ... von N Raschzok · · Zitiert von: 1 — ... Arndt Stahler,3 Lars Bullinger,3 Moritz Schmelzle,1 Wenzel Schöning,1 Georg Lurje,1 Felix Krenzien,1,2 Oliver Haase,1 Beate Rau,1 Bernhard ...
sortiert nach Relevanz / Datum